Penumbra (MEX:PEN) Tax Provision : MXN-195 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Penumbra Tax Provision?

Penumbra's tax provision for the three months ended in Mar. 2025 was MXN-95 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-195 Mil.

Penumbra Tax Provision Historical Data

The historical data trend for Penumbra's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra Tax Provision Chart

Penumbra Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Tax Provision

Get a 7-Day Free Trial

373.19

269.25

-114.91

191.88

-143.01

Penumbra Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Tax Provision	Get a 7-Day Free Trial															-60.15	323.79	-201.85	-222.24	-94.82

Penumbra Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-195 Mil.

Penumbra Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (MEX:PEN) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

PEN:USA 0P8:Germany

Address

One Penumbra Place, Alameda, CA, USA, 94502

Website

https://www.penumbrainc.com

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.